Anticoagulants and antiplatelets are medications taken to prevent blood clots and reduce the risk of cardiovascular events. Though both types of medications serve similar purposes, ...

Combined oral anticoagulant and antiplatelet therapy is associated with a worse prognosis than anticoagulation alone in newly diagnosed atrial fibrillation patients without a clear indication for ...

There was no difference in rates of stroke, residual stenosis, or occlusion at 1 year in patients treated with anticoagulants vs antiplatelet agents in the CADISS trial.

The risks to patients of medical or ophthalmic events surrounding cataract surgery are so low that patients need not alter their anticoagulant or antiplatelet use, according to a large study ...

The Scottish Dental Clinical Effectiveness program has provided a series of guidelines for dental patients on anticoagulants and antiplatelet drugs. This program is initiated by the National ...

Combined oral anticoagulant and antiplatelet therapy is associated with a worse prognosis than anticoagulation alone in newly diagnosed atrial fibrillation patients without a clear indication for ...

Antiplatelet vs Anticoagulant. Extracranial carotid and vertebral artery dissection is an important cause of stroke, accounting for about 1% of all strokes but about 25% of strokes in young people ...

Anticoagulants may come in a pill form or as an injection. Antiplatelets: These medications target platelets, which play a key role in blood clot formation . Antiplatelets usually come in pill form.

CannabinoidCannabis A recent review published in The Journal of Clinical Pharmacology summarizes the current literature evaluating the potential risks associated with concomitant use of cannabis ...

Of the 973 respondents with HHT, 700 (71.9%) stated they had never used antiplatelet or anticoagulant agents. Of these 700 respondents, 381 (54.4%) reported that they were advised by a doctor not ...

Newer oral anticoagulants are slated for a wide range of additional indications, ... J. Making headway in anticoagulant and antiplatelet therapy. Nat Rev Cardiol 12, 70–71 (2015) ...